Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib Maintenance in ED-SCLC
NCT03516084Phase 3Terminated
- Sponsor
- Zai Lab
- Start
- Aug 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niraparib in small cell lung cancer (SCLC), sponsored by Zai Lab. Started Aug 2018; status: terminated.
02
Drugs
niraparib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT03516084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03516084.